HT Image
HT Image

Daiichi Sankyo bids $4.6 bln for Ranbaxy

Japanese drug maker Daiichi Sankyo Co Ltd will pay up to $4.6 billion for control of India's Ranbaxy Laboratories Ltd.
By Edwina Gibbs and Devidutta Tripathy | Reuters, Tokyo/new Delhi
UPDATED ON JUN 11, 2008 06:44 PM IST

Japanese drug maker Daiichi Sankyo Co Ltd will pay up to $4.6 billion for control of India's Ranbaxy Laboratories Ltd, the latest in a string of global health deals as firms look to bulk up and diversify to fend off aggressive rivals.

The deal -- the second-largest foreign acquisition of an Indian company -- represents a major foray into the high-growth area of generic drugs for Daiichi Sankyo, following large overseas acquisitions by other Japanese drug makers.

Generic drug sales are booming as countries look to curb spiralling healthcare costs, but competition is intense. Drug makers worldwide are searching for new and emerging markets to drive profit growth as sales of traditional branded drugs in the United States, Europe and Japan start to slow.

The deal values Ranbaxy, India's biggest drugmaker by sales, at $8.5 billion, with the offer price at a 31.4 percent premium to its closing price on Tuesday.

"I like this deal very much," said Kenji Masuzoe, senior pharmaceuticals analyst at Deutsche Securities.

"The pure pharma business model has limitations and the industry has to think about hybrid models like pharma and agribusiness or pharma and generics," he said.

The deal would give Daiichi Sankyo operations in 60 countries, from 21 now, and make it around the 15th largest pharmaceutical company in the world, President and CEO Takashi Shoda said at the media conference in New Delhi.

Healthcare information group IMS Health estimates emerging market drug sales will hit $400 billion a year by 2020, equivalent to revenue today from the United States and Europe's top five markets combined, and contribute more than 50 percent to global market growth.

Generics are expected to play are pivotal role in accessing these large but relatively low-price markets, playing into the hands of Indian companies like Ranbaxy that have unrivalled expertise in developing cheap versions of medicines that are no longer covered by patents.

Ranbaxy is aiming for 20-25 per ent profit growth and 18-20 percent revenue growth for 2008. In the March quarter, its consolidated profit rose 7 per cent to 1.53 billion rupees. Consolidated sales were 16.2 billion rupees.

Daiichi Sankyo will buy the 34.8 per cent controlling stake held by Ranbaxy's founders, the Singh family, at 737 rupees per share. It will then make an open offer for up to a further 20 per cent of Ranbaxy shares that is mandatory under Indian regulations.

Daiichi Sankyo will also get preferential allotments of shares and share warrants, with a goal of a minimum 50.1 stake. The final holding would depend on the response to the open offer, and the companies said the transaction was expected to be worth between $3.4 billion to $4.6 billion.

Shares in Daiichi Sankyo, Japan's No 3 drug maker and best known for its high blood pressure medication Benicar, ended nearly 5 percent higher at 2,975 yen on Wednesday on early reports of a deal.

Ranbaxy's shares rose more than 5 per cent at one point, adding to gains of over 10 per cent in the previous two days. But the stock ended little changed as investors realised that some two-thirds of the shares in public hands would miss out on the premium offer.

Not a sellout

Ranbaxy CEO and Managing Director Malvinder Sigh told a news conference in New Delhi that his family had to sell their stake to clinch the deal.

"This is not a sell-out. This is a strategic deal to position the company and transform us to the next level," he said.

"This is my passion ... I love this business." said Singh, who will retain his role. Ranbaxy will remain listed in India.

Sarabjit Kour Nangra, vice president of research at Angel Broking, said it "was overdue for an overseas firm to acquire an Indian drug maker given the cost advantages we offer.

"Daiichi's offer for Ranbaxy is definitely a good one and valuations are quite satisfying."

The deal is second-biggest purchase of an Indian firm by a foreign company after Vodafone's $11 billion purchase of a controlling stake in a mobile operator last year, although that stake was held by another foreign firm.

Daiichi Sankyo, also in the media spotlight for its experimental blood thinner prasugrel that it is co-developing with Eli Lilly and Co, said the deal would be funded half in debt and half in equity.

Eager to ensure long-term growth and expand globally, Japan's biggest pharmaceutical companies have been ploughing profits made on top-selling medicines into acquisitions.

Takeda Pharmaceutical Co Ltd, Japan's biggest drug maker and maker of the popular Actos diabetes drug, just bought US biotech firm Millennium Pharmaceuticals for more than $8 billion to boost its cancer drug pipeline.

Eisai Co Ltd, Japan's fourth-largest drug maker and known for its Aricept drug to treat Alzheimer's, recently acquired cancer specialist MGI Pharma Inc for $3.9 billion.

Nomura Securities acted as the exclusive financial adviser to Daiichi Sankyo, while Religare Capital Markets, which is controlled by the Singh family, advised Ranbaxy.

SHARE THIS ARTICLE ON
app
Close
WhatsApp users received a notification this month that it was preparing a new privacy policy and terms, and it reserved the right to share some user data with the Facebook app.(REUTERS)
WhatsApp users received a notification this month that it was preparing a new privacy policy and terms, and it reserved the right to share some user data with the Facebook app.(REUTERS)

WhatsApp defers new policy on info sharing

By HT Correspondent, New Delhi
PUBLISHED ON JAN 16, 2021 11:38 PM IST
WhatsApp cancelled its February 8 deadline for accepting the tweak to its terms of service, involving sharing data with Facebook servers. The platform said it would instead “go to people gradually to review the policy at their own pace before new business options are available on May 15.”
Close
A bitcoin sculpture made from scrap metal is installed outside the BitCluster cryptocurrency mining farm in Norilsk, Russia.(Bloomberg)
A bitcoin sculpture made from scrap metal is installed outside the BitCluster cryptocurrency mining farm in Norilsk, Russia.(Bloomberg)

Bitcoin swings undermine CFO case for converting cash to cryptocurrency

Bloomberg
PUBLISHED ON JAN 16, 2021 09:16 PM IST
Chief financial officers, not generally known as a risk-loving bunch, watched Bitcoin sink more than 25% in a 24-hour period starting Sunday.
Close
Jimmy Tata, the chief credit officer, sold 1,400 shares of the bank held by him in what the lender termed as an "inadvertent trade".(Reuters)
Jimmy Tata, the chief credit officer, sold 1,400 shares of the bank held by him in what the lender termed as an "inadvertent trade".(Reuters)

HDFC Bank penalises its executive for inadvertently selling shares

PTI, Mumbai
PUBLISHED ON JAN 16, 2021 09:01 PM IST
The panel has determined that there was a violation of the Bank's Code and PIT Regulations and imposed a penalty of 10.20 lakh on Tata.
Close
Adani Group chairman Gautam Adani.(Reuters)
Adani Group chairman Gautam Adani.(Reuters)

Adani Group rebuts allegations, says no loan to it turned NPA

PTI, New Delhi
PUBLISHED ON JAN 16, 2021 08:43 PM IST
The ports-to-energy conglomerate said it has built stellar infrastructure assets in the nation adopting prudent corporate governance.
Close
The Mumbai-headquartered startup filed initial public offering documents with India’s market regulator on Friday.(AFP/For Representational Purposes Only)
The Mumbai-headquartered startup filed initial public offering documents with India’s market regulator on Friday.(AFP/For Representational Purposes Only)

Billionaire Jhunjhunwala-backed game startup Nazara starts India's tech IPO rush

Bloomberg
UPDATED ON JAN 16, 2021 08:23 PM IST
  • Founded by gamer Nitish Mittersain in 2000, when he was a college undergrad, Nazara is among the firms that have benefited from a global boom in smartphone gaming that began even before the pandemic drove millions online.
Close
Reserve Bank of India (RBI) governor Shaktikanta Das also said that the current COVID-19 pandemic-related shock will place greater pressure on the balance sheets of banks in terms of non-performing assets, leading to erosion of capital.
Reserve Bank of India (RBI) governor Shaktikanta Das also said that the current COVID-19 pandemic-related shock will place greater pressure on the balance sheets of banks in terms of non-performing assets, leading to erosion of capital.

RBI policies helped ease severity of economic impact of Covid-19: RBI Guv

PTI, New Delhi
PUBLISHED ON JAN 16, 2021 02:50 PM IST
With the principal objective during the pandemic to support economic activity, Das said, "looking back, it is evident that our policies have helped in easing the severity of the economic impact of the pandemic".
Close
Reserve Bank of India (RBI) governor Shaktikanta Das also said that the current COVID-19 pandemic-related shock will place greater pressure on the balance sheets of banks in terms of non-performing assets, leading to erosion of capital.
Reserve Bank of India (RBI) governor Shaktikanta Das also said that the current COVID-19 pandemic-related shock will place greater pressure on the balance sheets of banks in terms of non-performing assets, leading to erosion of capital.

Open to examine proposal on bad banks: RBI governor Shaktikanta Das

ANI, New Delhi
PUBLISHED ON JAN 16, 2021 02:27 PM IST
Talking about the governance reforms Das said integrity and quality of governance are keys to good health and robustness of banks and non-banking financial companies (NBFCs).
Close
RBI Governor Shaktikanta Das addresses media conference, in Mumbai on Friday. (ANI Photo)
RBI Governor Shaktikanta Das addresses media conference, in Mumbai on Friday. (ANI Photo)

Need to support economic revival, financial stability: RBI Governor

PTI, Chennai
PUBLISHED ON JAN 16, 2021 02:23 PM IST
The regulated entities on their part need to strengthen their internal defences to identify emerging risks early and manage them effectively.
Close
RBI Governor Shaktikanta Das addresses media conference, in Mumbai on Friday. (ANI Photo)
RBI Governor Shaktikanta Das addresses media conference, in Mumbai on Friday. (ANI Photo)

Emerging markets need reserves as shock buffers, says RBI governor Das

Bloomberg
PUBLISHED ON JAN 16, 2021 01:03 PM IST
India’s rupee was Asia’s worst performer last year, as the central bank countered relentless foreign investment inflows with dollar purchases.
Close
Nomura said that in sync with the ongoing growth upcycle, the economy will enter a Goldilocks period in the coming months as inflation continues to moderate.(AP)
Nomura said that in sync with the ongoing growth upcycle, the economy will enter a Goldilocks period in the coming months as inflation continues to moderate.(AP)

Virus fears return to haunt markets

By Nasrin Sultana, Mumbai
PUBLISHED ON JAN 16, 2021 08:56 AM IST
The BSE Sensex fell 549.49 points, or 1.11%, to 49,034.67, while the Nifty shed 161.90 points to 14,433.70. Shares in other Asia-Pacific regions were mostly lower. South Korea’s Kospi fell the most at 2.03%, while Japan’s Nikkei shed 0.62% and the Topix index 0.89%.
Close
India’s third-largest software services company by revenue posted a profit of Rs.3,982 crore in the three months ended December 31, a 26.7% increase from the previous quarter,(Pradeep Gaur/Mint File Photo)
India’s third-largest software services company by revenue posted a profit of Rs.3,982 crore in the three months ended December 31, a 26.7% increase from the previous quarter,(Pradeep Gaur/Mint File Photo)

HCL Tech Dec qtr profit jumps 27% to Rs.3,982 crore

By Nandita Mathur, New Delhi
PUBLISHED ON JAN 16, 2021 08:55 AM IST
The strong performance prompted HCL Tech to lift its revenue forecast for the March quarter. It expects revenue during the quarter to grow 2-3% in constant currency terms, up from its previous estimate of 1.5-2.5%.
Close
Imports expanded 7.56% last month, the first time in 10 months, while exports grew 0.14%—leaving a trade deficit of $15.44 billion, according to data released by the commerce ministry on Friday.(Bloomberg)
Imports expanded 7.56% last month, the first time in 10 months, while exports grew 0.14%—leaving a trade deficit of $15.44 billion, according to data released by the commerce ministry on Friday.(Bloomberg)

India’s trade deficit at 25-month high in Dec

By HT Correspondent | Livemint, New Delhi
UPDATED ON JAN 16, 2021 04:33 AM IST
India’s merchandise trade had been weakening even before the pandemic hit the economy and external demand. Since March 2020, both exports and imports started declining in high double digits, even temporarily leading to a trade surplus in June for the first time in 18 years.
Close
Refunds issued are received within 20-45 days from the date of completion of processing of ITR by the Centralized Processing Centre (CPC).(HT FILE PHOTO )
Refunds issued are received within 20-45 days from the date of completion of processing of ITR by the Centralized Processing Centre (CPC).(HT FILE PHOTO )

How to check income tax refund status online. Read here

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
PUBLISHED ON JAN 15, 2021 11:37 PM IST
  • Income tax refund (ITR) status can be checked on the National Securities Depository Limited (NSDL) website as well as on the income tax department’s e-filing site.
Close
U.S. industry operated at 74.5per cent of capacity in December, still below the pre-pandemic rate of 76.9per cent in February.(Representative image)
U.S. industry operated at 74.5per cent of capacity in December, still below the pre-pandemic rate of 76.9per cent in February.(Representative image)

US industrial production jumps 1.6 per cent in December

AP
UPDATED ON JAN 15, 2021 11:19 PM IST
The December gain in industrial output followed a 0.5per cent increase in November and a 1 per cent increase in October, the Federal Reserve reported Friday.
Close
The Signal messaging app logo is seen on a smartphone, in front of the same displayed same logo, in this illustration. (REUTERS)
The Signal messaging app logo is seen on a smartphone, in front of the same displayed same logo, in this illustration. (REUTERS)

Signal sees global outage, company says 'working hard to restore service'

Written by Meenakshi Ray
UPDATED ON JAN 15, 2021 11:18 PM IST
Site status tracker DownDetector showed there were 2,167 reports about the issue as users reported they could open the app and send messages but were being delivered later.
Close
SHARE
Story Saved
OPEN APP